Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Myopia
Share your love
Global trial equity: How LMIC data is reshaping US ophthalmology research | Ophthalmology Times
Incorporating data from low- and middle-income countries may help redefine how ophthalmology trials are designed, evaluated, and applied in practice (Image credit: AdobeStock/PUTRABATARA) Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins…
FDA approvals in 2025: What changed and why it matters for ophthalmologists | Ophthalmology Times
Editor’s Note: This content was generated with the assistance of AI. From first-in-class pharmacologic therapies to next-generation retinal durability strategies and less invasive surgical platforms, 2025 emerged as a pivotal year for the ophthalmic pipeline. Over the past 12 months,…
The year in optometry: 10 stories that defined eye care in 2025 | Ophthalmology Times
(Image Credit: AdobeStock) The past year marked a pivotal period for optometry, with 2025 delivering meaningful clinical, regulatory, and legislative developments that reshaped eyecare practice. Innovation remained front and center as the US FDA authorized Essilor’s Stellest lenses for myopia…
Prolonged digital device use increases risk of headaches, eye pain, and fatigue in children | Ophthalmology Times
(Image Credit: AdobeStock/NVB Stocker) A recent analysis examining the effects of screen time on the pediatric population has found that excessive use of digital devices can lead to both short- and long-term negative health outcomes. The analysis drew on a…
The future of glaucoma care: Where innovation meets everyday practice | Ophthalmology Times
Specialists in glaucoma care share insights on evolving strategies, technologies, and treatments shaping the future of patient management. (Image credit: AdobeStock) As glaucoma care continues to advance, ophthalmologists are embracing innovative technologies and new approaches that are reshaping diagnosis and…
Advancements in femtosecond laser technology benefit surgeons and patients | Ophthalmology Times
(Image Credit: AdobeStock/Wirestock) The field of refractive surgery has undergone multiple technological developments aimed at enhancing patient outcomes, optimizing workflows, and improving patient satisfaction. The VisuMax laser platform (Zeiss) is among the commercially available femtosecond laser systems and is used…
Precision strategy: Optimizing visual outcomes with advanced small-aperture lenses | Ophthalmology Times
(Image Credit: AdobeStock/Wirestock) A recent Ophthalmology Times Case-Based Roundtable addressed the pathway to achieving optimized visual outcomes using an advanced small-aperture IOL (IC-8 Apthera; Bausch + Lomb Surgical). Mark Lobanoff, MD, an ophthalmologist in St Louis Park, Minnesota, shared the highlights…
Proactive strategies and sustained delivery advance glaucoma care | Ophthalmology Times
(Image Credit: AdobeStock/Monkey Business) Proactive strategies in glaucoma care, including minimally invasive glaucoma surgery (MIGS) and physician decision-making, were the focus of a recent Ophthalmology Times Case-Based Roundtable, moderated by Sahar Bedrood, MD, PhD, a glaucoma specialist at Advanced Vision…
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment | Ophthalmology Times
The FDA has requested additional evidence for Sydnexis’ SYD-101, a 0.01% atropine eye drop aimed at slowing myopia progression in children, despite positive outcomes from the STAR clinical trial. (Image credit: Ophthalmology Times) The FDA has sent a complete response…
The mechanics of presbyopia: From muscle movement to functional vision | Ophthalmology Times
(Image Credit: AdobeStock) Presbyopia-correcting eye drops share a common mechanism: They are miotic agents designed to create a smaller pupil. The power of the pupil to extend depth of focus is impressive, as observed in patients with smaller pupils who…